Abstract:OBJECTIVE:To investigate the relationship between serum C-reactive protein (CRP) and metabolic disorders in individuals in Shanghai communities and to assess the value of CRP level on the risk of metabolic disorders.METHODS:A total of 5502 individuals (males 2379, females 3123) aged over 20 years with complete baseline data on metabolic syndrome (MS) and serum CRP from 1998 to 2001 in two communities of Shanghai were included. Highly sensitive CRP was tested by kinetics nephelometry. Quartiles of concentration of CRP were computed. Hyperglycemia (diabetes or impaired glucose regulation), hypertension, dyslipidemia, central obesity and MS were defined by WHO (1999) working definition of MS. Logistic regression model was used to estimate the relation between CRP level and relative risks of metabolic disorders.RESULTS:(1) In this two communities based population the prevalences of metabolic syndrome and its components were as follow: hyperglycemia 21.63% (diabetes 9.21%, impaired glucose regulation 12.41%), hypertension 32.95%, high triglyceride (TG)/low high-density lipoprotein cholesterol (HDL-C) 46.04%, central obesity 40.68% and metabolic syndrome 13.98%. (2) Serum CRP level was gradually elevated with the increment of ages in both men and women (P < 0.01). (3) Serum CRP level was increased with the increment of the components of metabolic disorders (P < 0.01). In individuals with MS, CRP level was higher than in those with 1 or 2 components of metabolic disorders (P < 0.01). (4) The highest quartile of CRP was 2.11 mg/L in men and 2.22 mg/L in women. (5) Compared with those in the lowest quartile, men in the highest quartile had increased relative risk of hyperglycemia (3.8 times), central obesity (5.5 times), hypertension (2.8 times), hyper triglyceride (1.3 times), low HDL-C (1.5 times) and MS (10 times). Similarly, women in the highest quartile had increased relative risk of hyperglycemia (7.7 times), central obesity (12.2 times), hypertension (6.1 times), hypertriglyceride (5.6 times), low HDL-C (1.1 times) and MS (8.5 times).CONCLUSION:(1) CRP level was related to the increment of age. (2) Individuals with more components of metabolic syndrome had higher serum CRP level. (3) The incidence of metabolic syndrome was increased with the increment of CRP level. The risk of metabolic disorders including hyperglycemia, hypertension, dyslipidemia, central obesity and metabolic syndrome was significantly elevated in men with CRP level over 2.11 mg/L and women with CRP level over 2.22 mg/L.

Study on the relationship between high-sensitivity C-reactive protein and carotid atherosclerosis in the patients with metabolic syndrome

The value of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: a cross-sectional study

Correlation of carotid artery atherosclerosis with C-reactive protein and adiponectin in patient with metabolic syndrome

Correlation between brachial ankle pulse wave velocity and high-sensitivity C-reactive protein in patients with metabolic syndrome

Study in the relationship between severity of coronary artery disease and high sensitive-C reaction protein as well as insulin resistance

Age‐ and Gender‐specific Prevalence of Carotid Atherosclerosis and Its Association with Metabolic Syndrome in Hangzhou, China

Association between metabolic syndrome and carotid atherosclerosis

Relationship between High-sensitivity C-reactive Protein and Subclinical Carotid Atherosclerosis Stratified by Glucose Metabolic Status in Chinese Adults.

Relationship Between Serum High Sensitivity C-Reative Protein and Atherosclerosis in Patients with Diabetes Mellitus

Relationship Between Serum High-Sensitivity C-reactive Protein and Coronary Heart Disease with Metabolic Syndrome

High Sensitivity C-reactive Protein is Associated with Carotid Intimal Medial Thickness in Type 2 Diabetes Mellitus

Relationship between carotid intima-media thickness and high sensitivity C-reactive protein in essential hypertension

Analysis of relationship between high- sensitivity C-reactive protein and carotid atherosclerosis in elderly hypertensive patients

The Clinical Value of Carotid Plaque Score in Patients with Metabolic Syndrome and Cardiovascular Diseases.

The Effect of Metabolic Syndrome on Carotid Artery Intima-Media Thickness in Patients with Essential Hypertension

Correlation study of metabolic syndrome and carotid atherosclerosis in patients with acute ischemic cerebrovascular diseases

E0019 Study on the Changes of Matrix Metalloproteinase-9 and High Sensitive C-reactive Protein in Patients with Carotid Intima-Media Thickness

The Relationship Between C-reactive Protein and Carotid Intimal Medial Thickness in Patients with Type 2 Diabetes Mellitus

Relationship of Carotid Intima-media Thickness with Serum High Sensitive C-reactive Protein and Insulin Resistance Risk Factors in Type 2 Diabetes Mellitus

[Association Between C-reactive Protein Level and Metabolic Syndrome and Components Thereof].

An Integrative View on the Carotid Artery Alterations in Metabolic Syndrome